6-Dec-2024 9:45 AM CST - Business Insider Moderna call volume above normal and directionally bullish Bullish option flow detected in Moderna (MRNA) with 29,554 calls trading, 1.7x expected, and implied vol increasing almost 2 points to 71.71%.
6-Dec-2024 8:22 AM CST - Yahoo Finance Here's Why We're Watching Moderna's (NASDAQ:MRNA) Cash Burn Situation So should Moderna ( NASDAQ:MRNA) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.
6-Dec-2024 6:19 AM CST - Business Insider Piper Sandler Keeps Their Buy Rating on Moderna (MRNA) In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna (MRNA - Research Report), with a price target
3-Dec-2024 9:24 AM CST - Investing Moderna shares could slump over 30% on negative CMV reading: Leerink Leerink analyst warned that Moderna (NASDAQ:MRNA) shares could fall more than 30% if interim results from its Phase 3 CMV vaccine trial, CMVictory gives negative readout. In case of a negative readout,
30-Nov-2024 6:17 PM CST - MSN Moderna, Inc. (MRNA): A Bull Case Theory We came across a bullish thesis on Moderna, Inc. (MRNA) on Substack by Natan. In this article, we will summarize the bulls' thesis on MRNA. Moderna, Inc. (MRNA)'s share was trading at $42.05 as of Nov 26th.
27-Nov-2024 11:12 PM CST - Business Insider RBC Capital Reaffirms Their Hold Rating on Moderna (MRNA) RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA - Research Report) on November 25 and set a price target of $50.00. The
26-Nov-2024 9:19 AM CST - Business Insider Moderna price target lowered to $45 from $59 at JPMorgan JPMorgan lowered the firm's price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. The firm updated
6-Dec-2024 9:45 AM CST - Business Insider Moderna call volume above normal and directionally bullish Bullish option flow detected in Moderna (MRNA) with 29,554 calls trading, 1.7x expected, and implied vol increasing almost 2 points to 71.71%.
6-Dec-2024 8:22 AM CST - Yahoo Finance Here's Why We're Watching Moderna's (NASDAQ:MRNA) Cash Burn Situation So should Moderna ( NASDAQ:MRNA) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.
6-Dec-2024 6:19 AM CST - Business Insider Piper Sandler Keeps Their Buy Rating on Moderna (MRNA) In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna (MRNA - Research Report), with a price target
3-Dec-2024 9:24 AM CST - Investing Moderna shares could slump over 30% on negative CMV reading: Leerink Leerink analyst warned that Moderna (NASDAQ:MRNA) shares could fall more than 30% if interim results from its Phase 3 CMV vaccine trial, CMVictory gives negative readout. In case of a negative readout,
30-Nov-2024 6:17 PM CST - MSN Moderna, Inc. (MRNA): A Bull Case Theory We came across a bullish thesis on Moderna, Inc. (MRNA) on Substack by Natan. In this article, we will summarize the bulls' thesis on MRNA. Moderna, Inc. (MRNA)'s share was trading at $42.05 as of Nov 26th.
27-Nov-2024 11:12 PM CST - Business Insider RBC Capital Reaffirms Their Hold Rating on Moderna (MRNA) RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA - Research Report) on November 25 and set a price target of $50.00. The
26-Nov-2024 9:19 AM CST - Business Insider Moderna price target lowered to $45 from $59 at JPMorgan JPMorgan lowered the firm's price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. The firm updated
